Latest News

California has introduced new driving laws affecting ignition interlock devices, penalties for intoxication related vehicular manslaughter, and rules for autonomous vehicles and electric motorcycles. Mercury General (NYSE:MCY), through its Mercury Insurance brand, has highlighted these legal updates for policyholders and investors. The company views the changes as relevant for risk assessment, claims patterns, and driver behavior in its core California market. For Mercury General, which...

Northern Star Resources (ASX:NST) has come under pressure after a second cut to its FY26 production guidance in two months, with operational challenges at KCGM and Jundee triggering a sharp share price reaction. See our latest analysis for Northern Star Resources. The A$21.75 share price reflects a sharp reset in expectations after the guidance cuts, with a 23.04% 1 month share price decline and a 10.97% year to date share price fall. However, the 1 year total shareholder return of 24.57% and...

FedEx (NYSE:FDX) has rolled out a reusable, collapsible packaging system aimed at cutting waste and improving logistics efficiency. The company plans to spin off FedEx Freight, reshaping its business structure and separating the less than truckload operations from its core express and ground services. FedEx has announced new AI deployments across its network, focused on routing, capacity planning and operational decision support. FedEx has surpassed UPS in market capitalization for the first...

Evaluating Bavarian Nordic after recent share performance Bavarian Nordic (CPSE:BAVA) has drawn attention after a mixed stretch for the shares, with a 1 day gain of about 2.2% but declines over the past week, month and past 3 months. For investors tracking longer horizons, the stock shows a positive 1 year total return and a modest gain over 3 years. This is set against a weaker 5 year outcome, which naturally raises questions about how the current valuation lines up with fundamentals. See...

What Oklo’s Recent Share Performance Tells You Oklo (OKLO) has drawn fresh attention after a mixed stretch in the stock, with a 1 day decline of 2.0% contrasting with a gain over the past week, as well as weaker performance over the past month and past 3 months. See our latest analysis for Oklo. At a latest share price of $58.37, Oklo’s recent 1 day and 1 month share price declines sit alongside a weaker year to date share price return. However, the 1 year and 3 year total shareholder returns...

MicroVision, Inc. has reported its full-year 2025 results, with sales of US$1.21 million compared to US$4.70 million in 2024 and a net loss of US$94.98 million versus US$96.92 million, while basic loss per share from continuing operations narrowed to US$0.35 from US$0.46. The combination of falling revenue and a slightly smaller loss highlights the company’s challenge of scaling its business while still tightly managing costs. With sales declining year over year but net loss narrowing, we’ll...

If you are wondering whether Ormat Technologies' current share price lines up with its underlying value, this article will walk you through the numbers in a straightforward way. The stock closed at US$110.38, with returns of 1.4% over 7 days, a 10.4% decline over 30 days, a 2.9% decline year to date, and a 54.4% return over 1 year, alongside 3 year and 5 year returns of 39.8% and 49.7% respectively. Recent coverage has focused on Ormat Technologies as a long standing player in the US...

If you are wondering whether Delta Air Lines is priced attractively right now, this article walks through what the current share price might imply about its underlying value. The stock last closed at US$58.78, with a 7 day return of 0.4% decline, a 30 day return of 17.7% decline, a year to date return of 14.9% decline, a 1 year return of 27.3%, and a 3 year return of 83.8%. Recent coverage around Delta has focused on how investors are reassessing major US airlines as a group, including...

Ardelyx recently reported the peer-reviewed publication of pooled clinical data showing its IBSRELA (tenapanor) therapy delivered earlier and sustained symptom relief in adults with IBS-C, with no new safety concerns identified. The analysis offers clinicians practical guidance on treatment duration and symptom timelines, potentially influencing how IBSRELA is positioned and used in everyday care. We’ll now examine how this new evidence of earlier and sustained IBS-C symptom relief could...

J. M. Smucker (NYSE:SJM) has launched Jif Simply Unsweetened Creamy Peanut Butter, a new peanut butter option without added sugar. The product targets health conscious shoppers looking for simple, plant based spreads with shorter ingredient lists. This launch expands the Jif lineup and reflects growing consumer interest in clean label pantry staples. J. M. Smucker, trading around $106.08, is leaning on its well known Jif franchise as it rolls out Jif Simply Unsweetened Creamy Peanut...

If you are looking at Everpure and wondering whether the current share price lines up with its underlying value, you are not alone. This article will walk through what the numbers are actually saying. Everpure last closed at US$61.50, with returns of 1.0% over 7 days, a 19.1% decline over 30 days, a 10.9% decline year to date, a 20.8% gain over 1 year and a very large return over 3 and 5 years. Recent moves in the share price have come alongside ongoing investor interest in the tech sector...

Zacks Equity Research recently highlighted Spire Inc.’s long-term infrastructure and innovation plans, including an expected US$11.20 billion in capital investments over the next decade, alongside its current 3.59% dividend yield and analyst estimates for long-term earnings growth. The analysis underscores how these planned investments and anticipated earnings expansion could influence Spire’s role in a gas utility sector balancing aging infrastructure, renewable competition, and the...

PACS Group (PACS) stock has been in focus after management used the latest earnings call to outline record revenue, firmer margins, and a 2026 outlook that points to higher revenue and EBITDA. See our latest analysis for PACS Group. At a share price of US$34.84, PACS Group has seen a 3.41% 1 day share price return and a 1.63% 7 day share price return. However, the 30 day share price return shows an 11.08% decline, which contrasts with a 1 year total shareholder return of 195%. This suggests...

In early March 2026, AECOM refinanced its existing credit facilities with an Amendment to its syndicated agreement, securing a new US$1.50 billion revolving credit facility, a US$950.00 million term loan A, and a US$500.00 million term loan B maturing in 2031, while its board separately declared a quarterly cash dividend of US$0.31 per share payable on April 17, 2026. The expanded, sustainability-linked credit facilities and continued dividend program highlight AECOM's focus on long-term...

If you are wondering whether Berkshire Hathaway is fairly priced today or if there is value still on the table, this article will walk through what the numbers are saying about the stock. The share price closed at US$490.03 recently, with returns of a 1.8% decline over 7 days, 2.0% decline over 30 days, 1.4% decline year to date and 4.8% decline over 1 year. The 3 year and 5 year returns sit at 67.0% and 95.2% respectively. Recent coverage around Berkshire Hathaway has focused on its role as...

McEwen (MUX) closed out FY 2025 with Q4 revenue of US$64.6 million and basic EPS of US$0.70, alongside net income of US$38.1 million, putting a clear marker on its latest financial run rate. Over the year, quarterly revenue ranged from US$35.7 million in Q1 to US$64.6 million in Q4, while basic EPS moved between a loss of US$0.12 and a gain of US$0.70, giving investors a wide view of how profitability has tracked against the top line. Overall, the results point to firmer margins in the latest...

Clarivate (NYSE:CLVT) has integrated its regulatory intelligence with Anthropic's Claude AI assistant. The collaboration embeds Clarivate's regulatory data directly into biopharma, biotech, and medtech AI workflows. The move is aimed at supporting regulatory affairs teams by keeping trusted data closer to day to day decision making. Clarivate focuses on data, analytics, and workflow tools for research driven industries, and life sciences is a core part of that mix. By plugging its...

Cellnex Telecom (BME:CLNX) has reported further purchases under its ongoing share buyback program, with a significant portion of the planned shares already repurchased. This puts capital returns and financial flexibility in focus for investors. See our latest analysis for Cellnex Telecom. Cellnex’s share buyback comes as the stock trades at €29.39, with a 90 day share price return of 15.12% and a year to date share price return of 7.18%. The 1 year total shareholder return is negative at...

CrowdStrike recently reported past fourth-quarter and full-year results showing higher revenue and its first positive quarterly GAAP net income, alongside new guidance for fiscal 2027, and followed this with browser- and cloud-focused security partnerships with Perplexity AI and Schwarz Digits’ STACKIT sovereign cloud in Europe. Together, these moves extend the Falcon platform deeper into AI-native workflows and EU-sovereign infrastructure, reinforcing CrowdStrike’s role in securing emerging...

Market snapshot: Westlake after recent price move Westlake (WLK) has pulled back around 1.9% over the past day, after a strong run in the past month and past 3 months, prompting some investors to reassess the stock’s recent momentum. See our latest analysis for Westlake. That 1 day share price pullback comes after a 7 day share price return of 8.6%, a 90 day share price return of 50.6%, and a 5 year total shareholder return of 32.3%. This suggests that momentum has been strong over longer...

In March 2026, Rapport Therapeutics reported a wider fourth-quarter and full-year 2025 net loss, while also filing new shelf registrations and granting Tenacia Biotechnology exclusive rights to develop and commercialize its clinical-stage candidate RAP-219 in Greater China in return for US$20 million upfront, potential milestone payments of about US$308 million, and tiered royalties. This licensing deal, combined with plans for global Phase 3 trials of RAP-219 in focal onset seizures,...

Earlier this month, CAE Inc. reshaped its defense leadership by appointing long-time executive Pascal Grenier as President, Defense & Security and naming Srini Dixit interim head of CAE Defense & Security USA, while also announcing the departure of Merrill Stoddard. Concurrently, TKMS announced a teaming agreement with CAE to develop training and simulation solutions for Canada’s future submarine program, potentially broadening CAE’s role in long-term naval training ecosystems at home and in...

Why Marubeni’s Branford Castle deal matters for shareholders Marubeni (TSE:8002) has drawn investor attention after committing capital to Branford Castle Partners’ new flagship fund and agreeing to work alongside the firm to source and support global investment opportunities. See our latest analysis for Marubeni. The Branford Castle agreement lands while Marubeni’s share price sits at ¥5,591, with a 1 day share price return of 4.02% and 7 day return of 3.86%. However, the 30 day share price...

In March 2026, On Holding AG reported fourth-quarter 2025 sales of CHF 743.8 million and full-year 2025 sales of CHF 3.01 billion, alongside lower net income compared to the prior year. At the same time, the company issued 2026 guidance calling for at least 23% constant-currency net sales growth, implying reported revenue of at least CHF 3.44 billion and signaling confidence in its ability to extend its recent top-line momentum. Next, we’ll examine how this at least 23% constant-currency...